Sarah is our Executive Director, Quality Assurance, having significant experience in the pharmaceutical industry in all aspects of Quality Management, Systems and Procedures.

As a consultant to industry, she provides GXP engaged auditing of quality systems in preparation for application, audit, and approvals of investigational medicinal products. Sarah is adept in conducting and managing pre-regulatory inspections and Audit preparation for FDA, HPRA and MHRA audits.